Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Smith

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
BMC Health Services Research|July 2, 2025
A patient self-report disability identifier within health service electronic medical records: evaluation of patient, carer and clinician acceptabilityJoanne Rowe, Alexandra Devine, Nicole Merrick, et al.
The Plant Cell|November 15, 2005
Functional genomic analysis of the AUXIN/INDOLE-3-ACETIC ACID gene family members in Arabidopsis thalianaPaul J Overvoorde, Yoko Okushima, José M Alonso, et al.
The Journal of Infectious Diseases|February 4, 2011
Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression ratesGabriel Catano, Zoya A Chykarenko, Andrea Mangano, et al.
Plos One|June 5, 2013
Elucidating the aetiology of human Campylobacter coli infectionsFrancois Roux, Emma Sproston, Ovidiu Rotariu, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2009
Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitorsJoanne L Thomson, Wesley P Blackaby, Andrew S R Jennings, et al.
Journal of Pharmaceutical Sciences|August 8, 2020
Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute MethodYang Liu, Janice Fernandez, Zheng Pu, et al.
Transfusion|June 2, 2020
From battlefront to homefront: creation of a civilian walking blood bankMaxwell A Braverman, Alison Smith, Charles Patrick Shahan, et al.
Mabs|June 15, 2017
A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgGXiaodong Xiao, Julie A Douthwaite, Yan Chen, et al.
BMC Research Notes|October 10, 2014
Lessons in participant retention in the course of a randomized controlled clinical trialOlubukola T Idoko, Olumuyiwa A Owolabi, Aderonke A Odutola, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
BMC Health Services Research|July 2, 2025
A patient self-report disability identifier within health service electronic medical records: evaluation of patient, carer and clinician acceptabilityJoanne Rowe, Alexandra Devine, Nicole Merrick, et al.
The Plant Cell|November 15, 2005
Functional genomic analysis of the AUXIN/INDOLE-3-ACETIC ACID gene family members in Arabidopsis thalianaPaul J Overvoorde, Yoko Okushima, José M Alonso, et al.
The Journal of Infectious Diseases|February 4, 2011
Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression ratesGabriel Catano, Zoya A Chykarenko, Andrea Mangano, et al.
Plos One|June 5, 2013
Elucidating the aetiology of human Campylobacter coli infectionsFrancois Roux, Emma Sproston, Ovidiu Rotariu, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2009
Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitorsJoanne L Thomson, Wesley P Blackaby, Andrew S R Jennings, et al.
Journal of Pharmaceutical Sciences|August 8, 2020
Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute MethodYang Liu, Janice Fernandez, Zheng Pu, et al.
Transfusion|June 2, 2020
From battlefront to homefront: creation of a civilian walking blood bankMaxwell A Braverman, Alison Smith, Charles Patrick Shahan, et al.
Mabs|June 15, 2017
A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgGXiaodong Xiao, Julie A Douthwaite, Yan Chen, et al.
BMC Research Notes|October 10, 2014
Lessons in participant retention in the course of a randomized controlled clinical trialOlubukola T Idoko, Olumuyiwa A Owolabi, Aderonke A Odutola, et al.
Pageof 24